| Website | stemgent.com |
| @Stemgent | |
| Category | BioTech |
| Phone | 617-245-0000 |
| Employees | |
| Founded | 2008 |
| Description | stem cell research |
| TOTAL | $37.2M |
| FUNDING TOTAL | $37.2M |
| Series B, 3/09 Frazier Healthcare Ventures Morgenthaler Ventures | $14M |
| Series B, 7/10 HealthCare Ventures Morgenthaler Ventures | $5.6M |
| Venture Round, 2/12 | $6.3M |
| Venture Round, 8/12 | $11.3M |
| DEBT TOTAL | $3.28M |
| Debt, 11/09 HealthCare Ventures Morgenthaler Ventures | $2.7M |
| Debt, 10/11 | $580k |
Stemgent works alongside some of the world’s leading stem cell scientists in developing innovative technology and application solutions that provide researchers the tools to investigate and understand cellular reprogramming. Our mission is to help simplify and support stem cell research by producing products and services being designed by leading stem cell researchers. Specialties Cellular Reprogramming, iPS Cells, Media, Human iPSC Training & Services, mRNA Reprogramming, Stem Cell Research, Custom iPS cell lines, Pluriton, WIT, StainAlive, NutriStem